U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, discusses the importance of ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Since the first-generation CAR-Ts reached the market several years ago, clinicians have become more adept at handling ...

Cell and gene therapy leaders say the agency’s decision to remove the Risk Evaluation and Mitigation Strategies that had been ...

Johnson & Johnson submitted a supplemental Biologics License Application to expand Stelara’s use to children aged two years ...

Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

In 1989, Johnson & Johnson sold its talc subsidiary. Instead of taking the opportunity to transition Johnson’s Baby Powder entirely to cornstarch, as other giants like Pfizer were doing, the company ...